Genome Medical has filed a notice of an exempt offering of securities to raise $75,344,304.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Genome Medical is raising up to $75,344,304.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jill Davies played a…
